Journal of Pharmacological Sciences (Jan 2005)

Cytotoxic Effect of the Her-2/Her-1 Inhibitor PKI-166 on Renal Cancer Cells Expressing the Connexin 32 Gene

  • Eriko Fujimoto,
  • Tomohiro Yano,
  • Hiromi Sato,
  • Kiyokazu Hagiwara,
  • Hiroshi Yamasaki,
  • Sumiko Shirai,
  • Keiko Fukumoto,
  • Hiromi Hagiwara,
  • Etsuko Negishi,
  • Koichi Ueno

Journal volume & issue
Vol. 97, no. 2
pp. 294 – 298

Abstract

Read online

We have reported that connexin (Cx) 32 acts as a tumor suppressor gene in renal cancer cells partly due to Her-2 inactivation. Here, we determined if a Her-2/Her-1 inhibitor (PKI-166) can enhance the tumor-suppressive effect of Cx32 in Caki-2 cells from human renal cell carcinoma. The expression of Cx32 in Caki-2 cells was required for PKI-166-induced cytotoxic effect at lower doses. The cyctotoxicity was dependent on the occurrence of apoptosis and partly mediated by Cx32-driven gap junction intercellular communications. These results suggest that PKI-166 further supports the tumor-suppressive effect of the Cx32 gene in renal cancer cells through the induction of apoptosis. Keywords:: connexin 32, PKI-166, renal cancer cell